Figure 2From: Performance of contrast enhanced SSFP and T2-weighted imaging for determining myocardium at risk in a multi-vendor, multi-center setting- data from the MITOCARE and CHILL-MI trialsNumber of diagnostic datasets by CESSFP and T2w compared to the total number of patients, grouped by vendor and altogether, respectively.Back to article page